Regeneron's announcement to acquire Decibal Therapeutics could potentially impact its stock price. The impact could be positive or negative depending on how investors perceive the acquisition and its potential benefits or risks for Regeneron.

The acquisition announcement by Regeneron has led to a surge in Decibal Therapeutics' share prices. This is a common reaction in the stock market as acquisitions often lead to increased investor confidence in the acquired company.